271 related articles for article (PubMed ID: 26375440)
1. miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.
Liu Y; Wang Y; Sun X; Mei C; Wang L; Li Z; Zha X
Oncotarget; 2016 Mar; 7(12):13491-501. PubMed ID: 26375440
[TBL] [Abstract][Full Text] [Related]
2. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
4. The PI3K-Akt pathway regulates calpain 6 expression, proliferation, and apoptosis.
Liu Y; Mei C; Sun L; Li X; Liu M; Wang L; Li Z; Yin P; Zhao C; Shi Y; Qiu S; Fan J; Zha X
Cell Signal; 2011 May; 23(5):827-36. PubMed ID: 21255642
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
6. POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Zhong Y; Huang H; Chen M; Huang J; Wu Q; Yan GR; Chen D
Oncotarget; 2017 Jul; 8(27):44082-44095. PubMed ID: 28489585
[TBL] [Abstract][Full Text] [Related]
7. CAPN6 Regulates Uterine Leiomyoma Cell Proliferation and Apoptosis through the Rac1-Dependent Signaling Pathway.
Zhu L; Sun Y; Wu Q; Zhang C; Ling J
Ann Clin Lab Sci; 2020 Jan; 50(1):24-30. PubMed ID: 32161009
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
[TBL] [Abstract][Full Text] [Related]
9. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
10. MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.
Chen SP; Liu BX; Xu J; Pei XF; Liao YJ; Yuan F; Zheng F
BMC Cancer; 2015 Oct; 15():706. PubMed ID: 26471185
[TBL] [Abstract][Full Text] [Related]
11. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
[TBL] [Abstract][Full Text] [Related]
12. miR-449a regulates biological functions of hepatocellular carcinoma cells by targeting SATB1.
Li J; Zheng Z; Zhang J; Tang Y; Wan X
J BUON; 2020; 25(3):1375-1382. PubMed ID: 32862579
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
14. The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer.
Xiao Y; Liu S; Li J; Dai W; Tang W; Xiang L; Zhang W; Lin J; Wang J; Wu X; Liu G; Liu Y; Chen Y; Zhu H; Wang Y; Lin Z; Yang Q; Chen T; Sun Y; Li A; Xiong J; Wang J
Cell Oncol (Dordr); 2020 Dec; 43(6):1017-1033. PubMed ID: 32857323
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
16. MiR-15b mediates liver cancer cells proliferation through targeting BCL-2.
Zhang Y; Huang F; Wang J; Peng L; Luo H
Int J Clin Exp Pathol; 2015; 8(12):15677-83. PubMed ID: 26884837
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.
Luo J; Chen P; Xie W; Wu F
Oncol Rep; 2017 Aug; 38(2):1067-1074. PubMed ID: 28677784
[TBL] [Abstract][Full Text] [Related]
19. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
20. miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.
Hernandez JM; Elahi A; Clark CW; Wang J; Humphries LA; Centeno B; Bloom G; Fuchs BC; Yeatman T; Shibata D
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S625-35. PubMed ID: 23864307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
